{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:05:57Z","timestamp":1792757157253,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s12325-008-0053-7","type":"journal-article","created":{"date-parts":[[2008,5,17]],"date-time":"2008-05-17T12:56:35Z","timestamp":1211028995000},"page":"430-437","source":"Crossref","is-referenced-by-count":37,"title":["Risk factors for cardiovascular disease in patients with subclinical hypothyroidism"],"prefix":"10.1007","volume":"25","author":[{"given":"Fusun","family":"Toruner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev E.","family":"Altinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Karakoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Yetkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goksun","family":"Ayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,15]]},"reference":[{"key":"53_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2265.1995.tb02615.x","volume":"43","author":"J. Franklyn","year":"1995","unstructured":"Franklyn J. \u2019subclinical hypothyroidism\u2019: to treat or not to treat, that is the question. Clin Endocrinol (Oxf). 1995;43:443\u2013444.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"53_CR2","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1210\/jcem.86.10.7959","volume":"86","author":"M.T. McDermott","year":"2001","unstructured":"McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab. 2001;86:4585\u20134590.","journal-title":"J Clin Endocrinol Metab."},{"key":"53_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1043-2760(03)00108-5","volume":"14","author":"P.J. Owen","year":"2003","unstructured":"Owen PJ, Lazarus JH. Subclinical hypothyroidism: the case for treatment. Trends Endocrinol Metab. 2003;14:257\u2013261.","journal-title":"Trends Endocrinol Metab."},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:24:1:001","volume":"24","author":"B. Biondi","year":"2004","unstructured":"Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004;24:1\u201313.","journal-title":"Endocrine."},{"key":"53_CR5","first-page":"155","volume":"6","author":"M.P. Vanderpump","year":"1996","unstructured":"Vanderpump MP, Tunbridge WM, French JM, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid. 1996;6:155\u2013160.","journal-title":"Thyroid."},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/105072503322238863","volume":"13","author":"R.D. Lindeman","year":"2003","unstructured":"Lindeman RD, Romero LJ, Schade DS, et al. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Thyroid. 2003;13:595\u2013600.","journal-title":"Thyroid."},{"key":"53_CR7","doi-asserted-by":"crossref","first-page":"M658","DOI":"10.1093\/gerona\/57.10.M658","volume":"57","author":"M.M. Mya","year":"2002","unstructured":"Mya MM, Aronow WS. Subclinical hypothyroidism is associated with coronary artery disease in older persons. J Gerontol A Biol Sci Med Sci. 2002;57:M658\u2013M659.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/hrt.46.2.202","volume":"46","author":"M. Tieche","year":"1981","unstructured":"Tieche M, Lupi GA, Gutzwiller F, et al. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J. 1981;46:202\u2013206.","journal-title":"Br Heart J."},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/thy.1997.7.411","volume":"7","author":"J. Lekakis","year":"1997","unstructured":"Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 1997;7:411\u2013414.","journal-title":"Thyroid."},{"key":"53_CR10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/jc.2003-031669","volume":"89","author":"F. Monzani","year":"2004","unstructured":"Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2004;89:2099\u20132106.","journal-title":"J Clin Endocrinol Metab."},{"key":"53_CR11","first-page":"2993","volume":"85","author":"M.D. Danese","year":"2000","unstructured":"Danese MD, Ladenson PW, Meinert CL, et al. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000;85:2993\u20133001.","journal-title":"J Clin Endocrinol Metab."},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2265.1996.739560.x","volume":"44","author":"B.C. Tanis","year":"1996","unstructured":"Tanis BC, Westendorp GJ, Smelt HM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf). 1996;44:643\u2013649.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-9150(02)00372-6","volume":"166","author":"M. Christ-Crain","year":"2003","unstructured":"Christ-Crain M, Meier C, Guglielmetti M, et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166:379\u2013386.","journal-title":"Atherosclerosis."},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.metabol.2004.05.016","volume":"53","author":"A. Perez","year":"2004","unstructured":"Perez A, Cubero JM, Sucunza N, et al. Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism. Metabolism. 2004;53:1512\u20131515.","journal-title":"Metabolism."},{"key":"53_CR15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/105072502760258721","volume":"12","author":"R. Deicher","year":"2002","unstructured":"Deicher R, Vierhapper H. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid. 2002;12:733\u2013736.","journal-title":"Thyroid."},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1081\/ERC-200033558","volume":"30","author":"E. Sengul","year":"2004","unstructured":"Sengul E, Cetinarslan B, Tarkun I, et al. Homocysteine concentrations in subclinical hypothyroidism. Endocr Res. 2004;30:351\u2013359.","journal-title":"Endocr Res."},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"W.T. Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem."},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"D.R. Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u2013419.","journal-title":"Diabetologia."},{"key":"53_CR19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/eje.0.1450705","volume":"145","author":"Z. Efstathiadou","year":"2001","unstructured":"Efstathiadou Z, Bitsis S, Milionis HJ, et al. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur J Endocrinol. 2001;145:705\u2013710.","journal-title":"Eur J Endocrinol."},{"key":"53_CR20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2265.2005.02399.x","volume":"63","author":"J.P. Walsh","year":"2005","unstructured":"Walsh JP, Bremner AP, Bulsara MK et al. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol (Oxf). 2005;63:670\u2013675.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"53_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1370\/afm.79","volume":"2","author":"W.J. Hueston","year":"2004","unstructured":"Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med. 2004;2:351\u2013355.","journal-title":"Ann Fam Med."},{"key":"53_CR22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/eje.1.01857","volume":"152","author":"S. Gullu","year":"2005","unstructured":"Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol. 2005;152:355\u2013361.","journal-title":"Eur J Endocrinol."},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/thy.2000.10.803","volume":"10","author":"T. Tzotzas","year":"2000","unstructured":"Tzotzas T, Krassas GE, Konstantinidis T, et al. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid. 2000;10:803\u2013808.","journal-title":"Thyroid."},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1567-5688(03)00028-X","volume":"4","author":"R. Maas","year":"2003","unstructured":"Maas R, Boger RH. Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atheroscler Suppl. 2003;4:5\u201317.","journal-title":"Atheroscler Suppl."},{"key":"53_CR25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2362.1982.tb00690.x","volume":"12","author":"S. Valdemarsson","year":"1982","unstructured":"Valdemarsson S, Hedner P, Nilsson-Ehle P. Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism. Eur J Clin Invest. 1982;12:423\u2013428.","journal-title":"Eur J Clin Invest."},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","volume":"12","author":"L.H. Duntas","year":"2002","unstructured":"Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12:287\u2013293.","journal-title":"Thyroid."},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1995.tb02616.x","volume":"43","author":"A.W. Kung","year":"1995","unstructured":"Kung AW, Pang RW, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf). 1995;43:445\u2013449.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"53_CR28","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0026-0495(95)90075-6","volume":"44","author":"R. Arem","year":"1995","unstructured":"Arem R, Escalante DA, Arem N, et al. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism. 1995;44:1559\u20131563.","journal-title":"Metabolism."},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1507\/endocrj.43.731","volume":"43","author":"M. Yildirimkaya","year":"1996","unstructured":"Yildirimkaya M, Ozata M, Yilmaz K, et al. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr J. 1996;43:731\u2013736.","journal-title":"Endocr J."},{"key":"53_CR30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.arcmed.2004.08.003","volume":"35","author":"W.Y. Lee","year":"2004","unstructured":"Lee WY, Suh JY, Rhee EJ, et al. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. Arch Med Res. 2004;35:540\u2013545.","journal-title":"Arch Med Res."},{"key":"53_CR31","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/me.2002-0009","volume":"16","author":"H. Gullberg","year":"2002","unstructured":"Gullberg H, Rudling M, Salto C, et al. Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol. 2002;16:1767\u20131777.","journal-title":"Mol Endocrinol."},{"key":"53_CR32","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1073\/pnas.1633737100","volume":"100","author":"G.J. Grover","year":"2003","unstructured":"Grover GJ, Mellstrom K, Ye L, et al. Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proc Natl Acad Sci U S A. 2003;100:10067\u201310072.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"53_CR33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2265.2005.02388.x","volume":"63","author":"W.J. Hueston","year":"2005","unstructured":"Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005;63:582\u2013587.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"53_CR34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","volume":"291","author":"M.I. Surks","year":"2004","unstructured":"Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228\u2013238.","journal-title":"JAMA."},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/thy.2005.15.24","volume":"15","author":"H. Gharib","year":"2005","unstructured":"Gharib H, Tuttle RM, Baskin HJ, et al. American Association of Clinical Endocrinologists; American Thyroid Association; The Endocrine Society. Consensus statement #1: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid. 2005;15:24\u201328.","journal-title":"Thyroid."},{"key":"53_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00024677-200605020-00001","volume":"5","author":"F. Monzani","year":"2006","unstructured":"Monzani F, Dardano A, Caraccio N. Does treating subclinical hypothyroidism improve markers of cardiovascular risk? Treat Endocrinol. 2006;5:65\u201381.","journal-title":"Treat Endocrinol."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-008-0053-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0053-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T20:11:16Z","timestamp":1588709476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-008-0053-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s12325-008-0053-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}